J. Parsonnet

发表

Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.

A. Stack, R. Saladino, C. Thompson, 1995, Critical care medicine.

Mediators in the pathogenesis of toxic shock syndrome: overview.

J. Parsonnet, 1989, Reviews of infectious diseases.

Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo

J. Parsonnet, P. Bonventre, M. Thompson, 1988, Infection and immunity.

Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.

J. Parsonnet, Z. Gillis, Jeffrey Parsonnet, 1988, The Journal of infectious diseases.

Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.

G. Pier, J. Parsonnet, Z. Gillis, 1986, The Journal of infectious diseases.

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods.

G. Schoolnik, P. Small, P. Hopewell, 1994, The New England journal of medicine.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Advances in the prevention and management of traveler's diarrhea.

D. Passaro, J. Parsonnet, 1998, Current clinical topics in infectious diseases.

Unusual presentation of cat scratch disease in a patient positive for antibody to the human immunodeficiency virus.

W. Marasco, J. Parsonnet, S. Lester, 1989, Reviews of infectious diseases.

Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group.

D. Bates, K. Kahn, R. Platt, 1997, The Journal of infectious diseases.

Outbreak of Skin Infections in College Football Team Members Due to an Unusual Strain of Community-Acquired Methicillin-Susceptible Staphylococcus aureus

J. Schwartzman, R. Goering, J. Parsonnet, 2009, Journal of Clinical Microbiology.

Harbingers of paroxysmal ventricular tachycardia in acute myocardial infarction.

J. Parsonnet, E. L. Rothfeld, W. McGorman, 1977, Chest.

Severe sepsis: variation in resource and therapeutic modality use among academic centers

D. Bates, K. Kahn, R. Platt, 2003, Critical care.

When heredity is infectious.

J. Parsonnet, 2000, Gastroenterology.

Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.

J. Parsonnet, A. Suriawinata, T. Kaneko, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Flagellar serotypes of Salmonella typhi in Indonesia: relationships among motility, invasiveness, and clinical illness.

G. Schoolnik, M. Lesmana, J. Parsonnet, 1995, The Journal of infectious diseases.

Prevalence of Toxic Shock Syndrome Toxin 1 (TSST-1)-Producing Strains of Staphylococcus aureus and Antibody to TSST-1 among Healthy Japanese Women

Michaelle B. Jones, C. Davis, R. Goering, 2008, Journal of Clinical Microbiology.

Utilization of a chromogenic Limulus amebocyte lysate blood assay in a multi-center study of sepsis

D. Bates, J. Parsonnet, B. Schlain, 1997 .

Arrhythmias induced by exercise in paced patients.

V. Parsonnet, J. Parsonnet, E. L. Rothfeld, 1974, American heart journal.

Chronic diarrhea associated with drinking untreated water.

R. Tauxe, C. Bopp, J. Parsonnet, 1989, Annals of Internal Medicine.

Prevalence of Toxic Shock Syndrome Toxin 1-Producing Staphylococcus aureus and the Presence of Antibodies to This Superantigen in Menstruating Women

J. E. Wild, Michaelle B. Jones, J. Parsonnet, 2005, Journal of Clinical Microbiology.

TNFÎ±-producing CD4+ T cells dominate the SARS-CoV-2-specific T cell response in COVID-19 outpatients and are associated with durable antibodies

C. Blish, Shin-ichiro Takahashi, B. Greenhouse, 2022, medRxiv.

Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.

N. Kuppermann, B. Hammer, C. Thompson, 1995, Critical care medicine.

Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

G. Pier, J. Parsonnet, R. K. Hickman, 1985, The Journal of infectious diseases.

SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses

G. Chertow, S. Anand, M. Montez-Rath, 2022, medRxiv.

Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.

R. Geha, T. Chatila, J. Parsonnet, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Structure-activity relationship of toxic-shock-syndrome toxin-1: derivation and characterization of immunologically and biologically active fragments.

J. Parsonnet, E. Kass, C. Edwin, 1988, The Journal of infectious diseases.

Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock.

C. Thompson, J. Parsonnet, G. Siber, 1992, Journal of Infectious Diseases.

EFFECT OF MEMNINGOCOCCAL ENDOTOXIN IN A RABBIT MODEL OF SHOCK

J. Parsonnet, G. Siber, G. Fleisher, 1990, Circulatory shock.

Long Term Accuracy of SARS-CoV-2 Interferon-γ Release Assay and its Application in Household Investigation

J. Andrews, S. Boyd, B. Pinsky, 2021, medRxiv.

Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus

M. Liu, R. Arbeit, J. Parsonnet, 1990, Journal of clinical microbiology.

Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins.

C. Thompson, J. Parsonnet, G. Siber, 1991, The Journal of infectious diseases.

Bacterial Infections of the Skin and Soft Tissues

J. Parsonnet, 2003 .

Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro.

J. Parsonnet, P. Modern, K. Giacobbe, 1996, The Journal of infectious diseases.

Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study.

P. Schlievert, J. Parsonnet, E. Kass, 1988, The Journal of infectious diseases.

A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1

G. Pier, J. Parsonnet, Z. Gillis, 1987, Infection and immunity.

Role of magnesium ion in the pathogenesis of toxic shock syndrome.

J. Parsonnet, E. Kass, J. T. Mills, 1987, Transactions of the Association of American Physicians.

A 42-year-old asplenic man with gram-negative sepsis

J. Versalovic, J. Parsonnet, 1999 .

Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

J. Parsonnet, M. Moro, W. A. Charini, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Azathioprine hypersensitivity mimicking sepsis in a patient with Crohn's disease.

J. Parsonnet, B. Wilson, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of sepsis syndrome in 8 academic medical centers.

D. Bates, K. Kahn, R. Platt, 1997, JAMA.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Vance G Fowler, Sara E Cosgrove, S. Cosgrove, 2006, The New England journal of medicine.

Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1

G. Pier, J. Parsonnet, Z. Gillis, 1985, Journal of clinical microbiology.

Persistence survey of Toxic Shock Syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women

J. E. Wild, Michaelle B. Jones, J. Parsonnet, 2010, BMC infectious diseases.

On the pathogenesis of toxic shock syndrome.

J. Parsonnet, E. Kass, 1987, Reviews of Infectious Diseases.

Structural and Functional Properties of Antibodies to the Superantigen TSST-1 and Their Relationship to Menstrual Toxic Shock Syndrome

C. Davis, M. Kotb, J. Parsonnet, 2007, Journal of Clinical Immunology.

Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus.

J. Parsonnet, E. Kass, M. Kendrick, 1987, The Journal of infectious diseases.

Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion.

J. Parsonnet, E. Kass, M. Kendrick, 1985, The Journal of infectious diseases.

Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.

D. Bates, K. Kahn, R. Platt, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.

M. Shoda, K. Ellenbogen, O. Wazni, 2017, Heart rhythm.

Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.

R. Geha, T. Chatila, J. Parsonnet, 1988, Journal of immunology.

Effect of a recombinant endotoxin‐neutralizing protein on endotoxin shock in rabbits

B. Hammer, R. Saladino, C. Thompson, 1994, Critical care medicine.

Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.

B. Hammer, R. Saladino, C. Thompson, 1994, Circulatory shock.

Hemolytic uremic syndrome: clinical picture and bacterial connection.

J. Parsonnet, P. Griffin, 1993, Current clinical topics in infectious diseases.

INFECTIOUS DISEASE ROUNDS

E. Nardell, J. Parsonnet, D. Zaleznik, 1988 .

Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci

J. Parsonnet, E. Kass, K. C. Parsonnet, 1987, Journal of clinical microbiology.

Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis*

D. Bates, K. Kahn, R. Platt, 2003, Critical care medicine.

Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus

B. Ransil, J. Parsonnet, P. Weller, 1989, Journal of clinical microbiology.

Is anything safe to eat?

J. Sobel, D. Swerdlow, J. Parsonnet, 2001, Current clinical topics in infectious diseases.

Resource Utilization Among Patients With Sepsis Syndrome

D. Bates, K. Kahn, R. Platt, 2003, Infection Control & Hospital Epidemiology.

Treatment of relapsed cutaneous Leishmania (Viannia) braziliensis infection with liposomal amphotericin B

J. Parsonnet, R. K. Devlin, S. Klaus, 2005 .

Severe Sepsis: Variation in Resource and Therapeutic Modality use Among Academic Centers

D. Bates, K. Kahn, R. Platt, 2003 .

Clinical Decision Support Trees Can Help Optimize Utilization of Anaplasma phagocytophilum Nucleic Acid Amplification Testing

J. Parsonnet, R. Hamilton, I. Martin, 2021, Journal of clinical microbiology.

Response of the Infectious Diseases Society of America Lyme Disease Review Panel to Johnson and Stricker

J. Parsonnet, M. Moro, W. A. Charini, 2010 .

Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.

R. Goering, M. Kotb, J. Parsonnet, 2013, Toxicological sciences : an official journal of the Society of Toxicology.

Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

J. Parsonnet, M. Moro, W. A. Charini, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment.

J. Parsonnet, J. Parsonnet, M. Barry, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.